Nagy Zoltán, Pánovics József, Harsányi László, Szendröi Attila, Szücs Miklós, Romics Imre
Semmelweis Egyetem I. sz. Sebészeti Klinika, Budapest.
Magy Seb. 2011 Dec;64(6):283-8. doi: 10.1556/MaSeb.64.2011.6.3.
Follow-up and review of patients who underwent surgery for renal cell cancer combined with tumor thrombus of the inferior vena cava at the Department of Urology Semmelweis University, Budapest, Hungary.
From l998 to 2010 twenty one patients underwent surgery for renal cell cancer combined with tumor thrombus of the inferior caval vein. Preoperative symptoms, TNM classification of the tumors, types of surgical interventions, complications, postoperative management and survival results were involved in the analysis. Mean follow-up period was 39 months, ranging from 3 to 101 months.
In five cases of level 3 thrombi the liver was mobilized without thoracotomy, and endoluminar occlusion was applied in one case. Intraoperative mortality was 9,5%. Survival time of patients with distant metastases was 12.1 months (3-9). Three patients without metastases died in the follow up period, their survival time was 26.7 months ranging from 22 to 31 months. Eight patients (73%) were alive at the time of the last follow-up. The mean survival time was 5.6 years ranging from 39 to 101 months.
Our results support that level 3 caval vein tumor thrombus can be removed by less aggressive surgical approach and underline the benefit of the surgical intervention without thoracotomy.
对匈牙利布达佩斯塞梅尔维斯大学泌尿外科接受肾细胞癌合并下腔静脉瘤栓手术的患者进行随访和复查。
1998年至2010年,21例患者接受了肾细胞癌合并下腔静脉瘤栓手术。分析内容包括术前症状、肿瘤的TNM分类、手术干预类型、并发症、术后管理和生存结果。平均随访期为39个月,范围从3个月至101个月。
在5例3级血栓病例中,未开胸进行肝脏游离,1例采用腔内闭塞术。术中死亡率为9.5%。远处转移患者的生存时间为12.1个月(3 - 9个月)。3例无转移患者在随访期死亡,其生存时间为26.7个月,范围从22个月至31个月。8例患者(73%)在最后一次随访时存活。平均生存时间为5.6年,范围从39个月至101个月。
我们的结果支持3级腔静脉瘤栓可通过侵袭性较小的手术方法切除,并强调了不开胸手术干预的益处。